KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Gains from Investment Securities (2016 - 2025)

Cme (CME) has disclosed Gains from Investment Securities for 16 consecutive years, with $600000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Gains from Investment Securities fell 91.67% to $600000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $8.2 million, a 132.54% increase, with the full-year FY2025 number at -$38.4 million, down 1380.0% from a year prior.
  • Gains from Investment Securities was $600000.0 for Q2 2025 at Cme, down from $8.2 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $12.5 million in Q3 2021 to a low of -$34.4 million in Q4 2023.
  • A 4-year average of -$185714.3 and a median of $3.6 million in 2023 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: plummeted 219.51% in 2021, then soared 327.78% in 2025.
  • Cme's Gains from Investment Securities stood at $9.4 million in 2021, then plummeted by 465.96% to -$34.4 million in 2023, then surged by 93.31% to -$2.3 million in 2024, then skyrocketed by 126.09% to $600000.0 in 2025.
  • Per Business Quant, the three most recent readings for CME's Gains from Investment Securities are $600000.0 (Q2 2025), $8.2 million (Q1 2025), and -$2.3 million (Q4 2024).